LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Lifevantage Corp
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 27, 2026
$5.98−0.02 (-0.33%)
Close on Oct 19, 2026
- Market cap
- $74.97M
- P/E (TTM)
- 15.0
- Dividend yield
- 3.09%
Lifevantage statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Lifevantage | Industry median |
|---|---|---|
| Market Cap | $74.91M | $166.30M |
| Enterprise Value | $59.99M | $87.12M |
| PE Ratio | 14.95 | 19.67 |
| PS Ratio | 0.41 | 3.60 |
| PB Ratio | 2.23 | 2.03 |
| P/TBV Ratio | 2.49 | 2.31 |
| P/FCF Ratio | 11.23 | 17.44 |
| P/OCF Ratio | 7.32 | 13.32 |
Enterprise value
| Measure | Lifevantage | Industry median |
|---|---|---|
| EV / Sales | 0.33 | 2.43 |
| EV / EBITDA | 6.76 | 14.69 |
| EV / EBIT | 9.84 | 18.47 |
| EV / FCF | 8.99 | 20.97 |
Income (trailing twelve months)
| Measure | Lifevantage | Industry median |
|---|---|---|
| Revenue | $182.59M | $57.94M |
| Gross Profit | $141.61M | $90.47M |
| Operating Income | $6.10M | -$21.49M |
| Pretax Income | $6.07M | -$14.72M |
| Net Income | $5.07M | -$22.46M |
| EBITDA | $8.87M | -$17.14M |
| EPS (Diluted) | $0.40 | -$0.83 |
Margins
| Measure | Lifevantage | Industry median |
|---|---|---|
| Gross Margin | 77.6% | 52.3% |
| Operating Margin | 3.34% | -44.5% |
| Pretax Margin | 3.32% | -13.0% |
| Profit Margin | 2.78% | -39.2% |
| EBITDA Margin | 4.86% | -31.3% |
| FCF Margin | 3.65% | -8.85% |
Returns
| Measure | Lifevantage | Industry median |
|---|---|---|
| Return on Equity (ROE) | 14.9% | -53.2% |
| Return on Assets (ROA) | 7.57% | -41.0% |
| Return on Invested Capital (ROIC) | 30.8% | -32.2% |
| Return on Capital Employed (ROCE) | 14.6% | -38.0% |
Growth
| Measure | Lifevantage | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -20.1% | 6.01% |
| Net Income Growth (YoY) | -48.3% | -37.7% |
| EPS Growth (YoY) | -46.7% | -29.2% |
| FCF Growth (YoY) | -36.5% | 2.34% |
| Revenue Growth (3Y CAGR) | -5.07% | 2.25% |
| Revenue Growth (5Y CAGR) | -3.68% | 6.42% |
| EPS Growth (3Y CAGR) | 26.0% | -0.17% |
| EPS Growth (5Y CAGR) | -15.0% | 3.77% |
Balance sheet
| Measure | Lifevantage | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $14.92M | $62.64M |
| Net Cash (Debt) | $14.92M | $15.77M |
| Net Cash Per Share | $1.19 | $0.66 |
| Equity (Book Value) | $33.59M | $48.61M |
| Book Value Per Share | $2.68 | $1.36 |
| Tangible Book Value | $30.07M | $23.01M |
| Working Capital | $18.07M | $75.09M |
Financial position
| Measure | Lifevantage | Industry median |
|---|---|---|
| Current Ratio | 1.89 | 3.30 |
| Quick Ratio | 0.89 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Lifevantage | Industry median |
|---|---|---|
| Operating Cash Flow | $10.24M | -$12.39M |
| Capital Expenditures | -$3.57M | -$1.07M |
| Free Cash Flow | $6.67M | -$20.34M |
| FCF Per Share | $0.53 | -$0.42 |
Efficiency
| Measure | Lifevantage | Industry median |
|---|---|---|
| Asset Turnover | 2.72 | 0.38 |
| Inventory Turnover | 2.22 | 2.67 |
| Revenue Per Employee | $818.77K | $398.96K |
| Profits Per Employee | $22.74K | -$705.27K |
| Employee Count | 223 | 74 |
Dividends and yields
| Measure | Lifevantage | Industry median |
|---|---|---|
| Earnings Yield | 6.77% | -22.8% |
| FCF Yield | 8.90% | -9.02% |
| Dividend Yield | 3.09% | 1.82% |
| Buyback Yield | 2.73% | -0.73% |
| Shareholder Yield | 5.82% | 0.00% |
| Dividend Per Share | $0.18 | $0.83 |
| Dividend Growth (YoY) | 12.1% | 2.37% |
| Years of Dividend Growth | 1 | 0 |
| Payout Ratio | 46.2% | 47.7% |
| FCF Payout Ratio | 35.1% | 51.6% |
Shares
| Measure | Lifevantage | Industry median |
|---|---|---|
| Shares Outstanding | 12,527,300 | 58,139,000 |
| Shares Change (YoY) | -2.19% | 11.1% |
| Shares Change (QoQ) | -0.72% | 0.54% |
| Float | 9,390,750 | 49,154,900 |
| Shares Held by Insiders | 25.0% | 11.6% |
| Shares Held by Institutions | 47.2% | 59.4% |
Taxes
| Measure | Lifevantage | Industry median |
|---|---|---|
| Income Tax | $994.00K | $89.00K |
| Effective Tax Rate | 16.4% | 20.5% |
Scores
| Measure | Lifevantage | Industry median |
|---|---|---|
| Graham Number | $4.91 | $17.04 |
| Graham Upside | -17.9% | -44.3% |
| Altman Z-Score | 2.86 | -0.27 |
| Piotroski F-Score | 6 | 4 |
| Beneish M-Score | -2.73 | -2.62 |
Calculated by StockData from Lifevantage's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.